SG Americas Securities LLC Buys 256,669 Shares of Acadia Healthcare Company, Inc. $ACHC

SG Americas Securities LLC boosted its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 717.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 292,425 shares of the company’s stock after buying an additional 256,669 shares during the period. SG Americas Securities LLC owned approximately 0.32% of Acadia Healthcare worth $4,150,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of ACHC. EverSource Wealth Advisors LLC lifted its holdings in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares during the last quarter. Public Employees Retirement System of Ohio lifted its stake in Acadia Healthcare by 2.8% in the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock worth $776,000 after purchasing an additional 867 shares during the last quarter. Treasurer of the State of North Carolina boosted its position in shares of Acadia Healthcare by 2.1% during the second quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after buying an additional 867 shares during the period. Verdence Capital Advisors LLC grew its stake in shares of Acadia Healthcare by 7.2% during the third quarter. Verdence Capital Advisors LLC now owns 15,715 shares of the company’s stock valued at $361,000 after buying an additional 1,059 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky raised its holdings in shares of Acadia Healthcare by 1.5% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 79,730 shares of the company’s stock worth $1,974,000 after buying an additional 1,141 shares during the period.

Analyst Ratings Changes

Several equities analysts have commented on ACHC shares. UBS Group upped their price objective on Acadia Healthcare from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Thursday, February 26th. TD Cowen upped their price target on shares of Acadia Healthcare from $22.00 to $24.00 and gave the stock a “buy” rating in a report on Thursday, February 26th. Mizuho decreased their price objective on shares of Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating for the company in a report on Thursday, December 18th. Raymond James Financial reaffirmed an “outperform” rating and set a $25.00 target price on shares of Acadia Healthcare in a research report on Thursday, February 26th. Finally, Zacks Research upgraded Acadia Healthcare from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. Seven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $21.15.

Acadia Healthcare Stock Up 1.2%

Shares of ACHC stock opened at $23.96 on Friday. Acadia Healthcare Company, Inc. has a 1-year low of $11.43 and a 1-year high of $30.17. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.55 and a quick ratio of 1.55. The company has a market cap of $2.21 billion, a price-to-earnings ratio of -1.96, a price-to-earnings-growth ratio of 8.00 and a beta of 0.71. The stock’s fifty day moving average price is $19.59 and its 200 day moving average price is $18.84.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.04. The company had revenue of $821.46 million during the quarter, compared to analysts’ expectations of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. Acadia Healthcare’s revenue for the quarter was up 6.1% on a year-over-year basis. During the same period last year, the business earned $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. On average, research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.